{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:57:00Z","timestamp":1794283020629,"version":"4.9.0"},"reference-count":63,"publisher":"American Society for Clinical Investigation","issue":"17","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health NIAID","doi-asserted-by":"crossref","award":["R01AI114780"],"award-info":[{"award-number":["R01AI114780"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Conquer Myasthenia Gravis","award":["pilot research award"],"award-info":[{"award-number":["pilot research award"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,7]]},"abstract":"<jats:p>\n                    Myasthenia gravis (MG) is a B cell\u2013mediated autoimmune disorder of neuromuscular transmission. Pathogenic autoantibodies to muscle-specific tyrosine kinase (MuSK) can be found in patients with MG who do not have detectable antibodies to the acetylcholine receptor (AChR). MuSK MG includes immunological and clinical features that are generally distinct from AChR MG, particularly regarding responsiveness to therapy. B cell depletion has been shown to affect a decline in serum autoantibodies and to induce sustained clinical improvement in the majority of MuSK MG patients. However, the duration of this benefit may be limited, as we observed disease relapse in MuSK MG patients who had achieved rituximab-induced remission. We investigated the mechanisms of such relapses by exploring autoantibody production in the reemerging B cell compartment. Autoantibody-expressing CD27\n                    <jats:sup>+<\/jats:sup>\n                    B cells were observed within the reconstituted repertoire during relapse but not during remission or in controls. Using two complementary approaches, which included production of 108 unique human monoclonal recombinant immunoglobulins, we demonstrated that antibody-secreting CD27\n                    <jats:sup>hi<\/jats:sup>\n                    CD38\n                    <jats:sup>hi<\/jats:sup>\n                    B cells (plasmablasts) contribute to the production of MuSK autoantibodies during relapse. The autoantibodies displayed hallmarks of antigen-driven affinity maturation. These collective findings introduce potential mechanisms for understanding both MuSK autoantibody production and disease relapse following B cell depletion.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.94263","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T17:27:40Z","timestamp":1504718860000},"source":"Crossref","is-referenced-by-count":103,"title":["Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis"],"prefix":"10.1172","volume":"2","author":[{"given":"Panos","family":"Stathopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/85520"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2012.01.025"},{"issue":"2","key":"B3","first-page":"255","article-title":"Clinical characteristics of refractory myasthenia gravis patients","volume":"86","author":"Suh","year":"2013","journal-title":"Yale J Biol Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182407982"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303664"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.4190"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06781.x"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22006"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/1756285611411503"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.220475"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25597"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000077"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.311"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601415"},{"issue":"175","key":"B16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115723"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/art.11181"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.236"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501843"},{"key":"B21","first-page":"85","article-title":"Roles of Plasmablasts and B Cells in IgG4-Related Disease: Implications for Therapy and Early Treatment Outcomes","volume":"401","author":"Lanzillotta","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2010.03.009"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.04.015"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.01.011"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.01.013"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.09.006"},{"key":"B27","first-page":"S47","article-title":"Human peripheral blood B-cell compartments: a crossroad in B-cell traffic","volume":"78 Suppl 1","author":"Perez-Andres","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04206.x"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097087"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205233"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062930"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.02.017"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.3071"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1017385108"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083036"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.39455"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202893"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/art.38754"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067752"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1508234"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.4.577"},{"issue":"1","key":"B42","first-page":"97","article-title":"Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis","volume":"58","author":"Willcox","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301555"},{"issue":"4","key":"B44","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.158.4.1919","article-title":"Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies","volume":"158","author":"Graus","year":"1997","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-341917"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1210"},{"issue":"12","key":"B47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93222","article-title":"Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab","volume":"2","author":"Cho","year":"2017","journal-title":"JCI Insight"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(95)00101-8"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/9.9.1311"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.4.1935"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.034"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nature06890"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3175"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701132"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24185"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21802"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000228225.23349.5d"},{"issue":"101","key":"B58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002432","article-title":"A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis","volume":"3","author":"Owczarczyk","year":"2011","journal-title":"Sci Transl Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20748"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(99)00184-2"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046709"},{"issue":"Pt 7","key":"B62","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-842-9_32"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/94263\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:34:14Z","timestamp":1779197654000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/94263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":63,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2017,9,7]]},"published-print":{"date-parts":[[2017,9,7]]}},"alternative-id":["10.1172\/jci.insight.94263"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.94263","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1172\/jci.insight.94263ds1","asserted-by":"subject"}]},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]},"article-number":"e94263"}}